Navigating the Challenging Biotech Funding Landscape Strategies to Conserve Resources and Accelerate Innovation The biotech industry stands at the forefront of scientific innovation, offering the promise of groundbreaking therapies that can transform healthcare. However, the journey from concept to commercialization is fraught with challenges, and securing funding has never been more demanding. In this article, we’ll explore a comprehensive set of Read more
Clinical Research Focus. 22nd Edition Fit-for-Purpose Biotech – CRO Collaboration: The FSP Model In the evolving biotech landscape, the Functional Service Provider (FSP) model is a strategic alliance that offers biotech companies the ability to access specialized services and expertise in specific drug development areas. Unlike traditional outsourcing, FSP models bring a new level of flexibility, enabling biotech firms to Read more
Cromos Pharma’s CEO Reflections on ESMO 2023: A Glimpse into The Future Of Oncology The European Society for Medical Oncology (ESMO) 2023 conference has drawn to a close, leaving the global biotech and medical community abuzz with the latest groundbreaking developments in the field of oncology. This year’s conference showcased an array of promising reports and advancements that have captivated the attention of industry professionals and physicians. As the Read more
Fit-for-Purpose Biotech – CRO Collaboration: The FSP Model In the evolving landscape of biotechnology and pharmaceutical research, the right level of collaboration is paramount. When working with Contract Research Organizations (CROs), many biotech professionals are turning to Functional Service Provider (FSP) models to enhance efficiency, flexibility, and the seamless integration of external expertise. What is an FSP Model? An FSP model is a Read more
